[Skip to Content]
[Skip to Content Landing]
July 17, 2013

The International Registry Infrastructure for Cardiovascular Device Evaluation and Surveillance

Author Affiliations
  • 1Department of Public Health and Cardiac Surgery, Weill Cornell Medical College, Cornell University, New York, New York
  • 2Division of Epidemiology, Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, Maryland
  • 3Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota
JAMA. 2013;310(3):257-259. doi:10.1001/jama.2013.7133

Since the creation of the US Food and Drug Administration (FDA) Medical Device Epidemiology Network (MDEpiNet),1 there has been an increasing FDA commitment to support the development of a global medical device research and surveillance infrastructure. The FDA’s new postmarket surveillance plan2 strengthens this commitment and highlights the importance of national and international registries, and multi-stakeholder involvement for ensuring this commitment is fulfilled. This Viewpoint summarizes the potential for development of an International Consortium of Cardiovascular Registries, modeled on a consortium established for orthopedic devices, as an initial project in the realm of cardiovascular devices with the focus on transcatheter aortic valve replacement (TAVR).

First Page Preview View Large
First page PDF preview
First page PDF preview